Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

All SEC Filings

Date Form Description PDF XBRL Pages
08/13/18 8-K Current report filing
Documents
12
08/10/18 10-Q Quarterly report pursuant to Section 13 or 15(d) 43
07/23/18 EFFECT Notice of Effectiveness 1
07/13/18 CT ORDER Confidential treatment order 1
07/12/18 S-1 General form of registration statement for all companies including face-amount certificate companies
Documents
29
06/27/18 S-8 POS Post-effective amendment to a S-8 registration statement
Documents
18
06/25/18 S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Documents
17
06/21/18 8-K Current report filing 91
06/21/18 424B5 Prospectus filed pursuant to Rule 424(b)(5) 34
06/20/18 8-K Current report filing
Documents
5
RSS